HIBICLENS® has been a trusted partner of healthcare professionals for over 30 years, repeatedly demonstrating its efficacy and safety. Recent studies and recommendations continue to reinforce its effectiveness, particularly in Intensive Care Units.

Clinical studies have shown that a 4% CHG solution, such as HIBICLENS, can help reduce facility infection rates, resulting in a significant economic gain. This antimicrobial antiseptic skin cleanser can be an effective defense for preventing the spread of MRSA and other staph infections in your facilities. Its active ingredient, chlorhexidine gluconate, works in a unique way - it kills germs on contact and bonds with the skin to keep killing microorganisms even after washing.